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Abstract 
The aim of this work was to assess the link between a 
newly identified KCNQ1 mutation and the short QT 
syndrome clinically observed in the patients. We applied 
two human Action Potential models, the ten Tusscher -
Panfilov (TTP) and the O’Hara Rudy (ORd). We also 
simulated the effects of adrenergic stimulation on action 
potential, since the basal adrenergic tone should likely 
affect the IKs influence on QTc in vivo. Finally, we 
simulated the pseudo ECG taking into account the 
heterogeneity of the cardiac wall. 
Simulations predict a shortening of the action potential 
consistent with the patient phenotype: using the TTP 
model the shortening was largely more pronounced (e.g. 
from 397 to 297 ms in M cells) than with the ORd (e.g. 
from 332 to 318 ms in M cells). When simulating the β-
adrenergic stimulation, the APD shortening was 
enhanced in ORd model. 
Pseudo ECG results confirm the reduction of the QT 
interval caused by mutation. 
1. Introduction
Sudden cardiac death in a young person is a shocking 
event that has puzzled physicians for decades. In recent 
years, many of the underlying cardiac pathologies have 
been discovered. These include structural abnormalities 
such as hypertrophic cardiomyopathy and nonstructural 
disorders associated with unstable rhythms that lead to 
sudden cardiac death. 
The best known of these “channelopathies” are the 
long QT syndromes, which result from abnormal 
potassium and sodium currents in cardiomyocytes. More 
recently, interest has been growing in a disorder that may 
carry a similarly prognosis but that has an opposite 
finding on electrocardiography (ECG), the Short QT 
syndrome (SQT). SQT is a heterogeneous genetic 
channelopathy that causes both atrial and ventricular 
arrhythmias and that has been documented to cause 
sudden cardiac death (SCD) in the setting of an 
abnormally short QT interval, ranging from 248 to 300 
ms (Bazett corrected QT, (QTc)), and structurally normal 
heart. Six genes encoding ion channel subunits have been 
implicated in the pathogenesis of SQT syndrome, and 
further genetic culprits are suspected. 
SQT2 is caused by gain of function mutations in the 
KCNQ1 gene encoding the alpha subunit of the Kv7.1 
channel (IKs) [3]. The index case of the family was a 37 
years old man who died unexpectedly. His son, an athletic 
healthy 23 years old, was referred recently for cardiac 
evaluation. ECG showed sinus bradycardia (55bpm), 
normal PR, QRS, and slightly short QTc interval of 
356ms. Exercise test was normal of note; QTc shortened 
with the exercise, measuring 350ms at maximum 
workload.  
In this study, we investigate and simulate the 
biophysical and cellular phenotype of a new 
characterized KCNQ1 mutation, F279I, found in a 
patient with SQT, on the action potential clamp and on 
the pseudo ECG using two different human cardiac 
action potential (AP) models, the ten Tusscher-Panfilov 
(TTP) and O’Hara-Rudy (ORd). 
2. Methods
2.1. Electrophysiology technique 
A blood sample from the patient and his sister was sent 
for genetic study of most prevalent genes related to 
channelopathies. Genetic studies on the index case son’s 
DNA excluded mutations in KCNH2, SCN5A, KCNE1, 
KCNE2, KCNJ2 and RyR2. Analysis of the KCNQ1 gene 
revealed a novel heterozygous mutation (change from 
phenylalanine to isoleucine at 279 in Kv7.1 (p.F279I) 
within the S5 transmembrane segment), which was not 
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reported before. Among the Kv7 family Kv7.1 is the 
unique channel carrying a phenylalanine at the equivalent 
position; suggesting that this residue might be important 
for the unique properties of the cardiac IKs. No other 
potential SQT mutations were identified and neither in his 
daughter. To examine the effects of the F279I in this 
physiologically relevant channel complex, either wild 
type (WT) Kv7.1 or the mutant F279I subunit were co-
transfected with KCNE1. 
Membrane currents were measured using the 
perforated-patch configuration of the patch-clamp 
technique with the amphotericin. Currents were recorded 
using an Axopatch 200B amplifier (Axon Instruments), 
were filtered at 1 kHz (4-pole Bessel filter) and sampled 
at 2 kHz. Micropipettes were pulled from borosilicate 
glass capillary tubes (Narishige, GD-1) on a 
programmable horizontal puller (Sutter Instruments Co.) 
and heat-polished with a microforge (Narishige). 
Micropipette resistance was 1-3 MΩ. Capacitance and 
series resistance compensation were optimized. pClamp 
version 9 software (Axon Instruments) was used for data 
acquisition and analysis. Currents were recorded at room 
temperature (21-23ºC) at a stimulation frequency of 0.03 
Hz. The voltage dependence of activation curves were 
fitted with a Boltzmann equation: y = 1/[1 + exp((V
Vh)/s)], in which s represents the slope factor, V the 
membrane potential and Vh the voltage at which 50% of 
the channels are open. 
 
2.2. Computational analysis 
To evaluate the electrophysiological consequences of 
the F279I mutation at the level of the cardiac AP, we 
introduced the IKs model obtained with the mutation, 
modifying the ten Tusscher-Panfilov (TTP) human 
ventricular myocyte model [1]. We changed the activation 
kinetics in agreement with voltage-clamp recordings of 
Kv7.1 current in the presence of KCNE1 to simulate the 
mutant condition (Table 1).  
To test the model-dependency of the simulation 
results, we carried out the simulation also using the 
O’Hara-Rudy (ORd) human ventricular myocyte model 
[2]. We repeated all the simulations, with both models, by 
introducing the effects of β-adrenergic stimulation by 
increasing IKs, (scaled by a factor of 2.66), ICaL (scaled by 
a factor of 1.5) and Iup (scaled by a factor of 1.5) 
according to a previous computational study [4]. 
Single cell simulations. Model differential equations 
were implemented in Matlab (Mathworks Inc., Natick, 
MA, USA) and solved with a variable order solver 
(ode15s). Pacing at 1 Hz was maintained until a steady 
state AP was reached and APD was measured as the 
interval between AP upstroke and the 90% repolarization 
level (APD90). 
Multicellular simulations. One dimensional fiber 
(1.64 cm length) composed by 25 endo-, 25 M-, 50 mid- 
and 65 epi-cardial cells has been considered. Model 
equations have been translated into cellML language 
using COR environment and monodomain equations have 
been solved with Chaste Software [5]. Pseudo-ECG 
signal has been computed as described by Glukhov et al. 
[6]. 
 
3.  Results 
3.1.  Electrophysiological results 
The mutant channel displayed ~1.8 fold acceleration of 
the fast component of the activation kinetics in 
comparison to the WT (Table 1). Furthermore, the initial 
sigmoidal activation, characteristic of WT was absent 
(Figure 1, middle panel). 
The voltage dependence of channel opening for the 
mutant was shifted towards more negative potentials, 
without changes in the slope (Figure 1, bottom panel; 
Table 1). Altogether, the shift in the activation curve and 
the faster activation kinetics indicate that F279I channels 
open faster and at more negative potentials than WT 
channels. These biophysical properties would predict a 
gain of function. 
 
Table 1. Activation kinetics and voltage dependence of 
WT and F279I channels. Vh is the voltage at which 50% 
of the channels are open, s represents the slope, τf and τs 
are the time course of activation, fast and slow, 
respectively. 
mean±SEM *: P<0.001; **: P<0.01. 
 
Table 2. Action potential duration at 90% 
repolarization (APD90) of ventricular (endocardial, 
epicardial and midmyocardial) cells with WT and F279I 
IKs, without and with β-adrenergic stimulation (β-as), 
simulated with TTP and ORd models. 
 WT F279I 
Vh (mV) 32.7 ± 3.2     7.0 ± 4.1* 
s (mV) 17.1 ± 0.8 17.9 ± 1.2 
τf (ms) 794.1 ± 35.9     431.8 ± 27.4** 
τs (ms) 3564.3 ± 481.2 2781.5 ± 209.6 
  APD90 (ms) 
  Endo Epi M 
  TTP   ORd TTP   ORd   TTP  ORd 
 
Basal 
WT 300     261 301     228 397     332 
F279I 194     251 196     220 297     318 
 
β-as 
WT 242     246 242     211 340     297 
F279I 149     226 151     195 238     274 
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 Figure 1. Top: voltage clamp protocol; pulses were 
applied from a holding potential of -80 mV to +100 mV 
in 20 mV-steps. Tail currents were recorded at -50 mV. 
Middle: WT (left) and F291I (right) currents records. 
Bottom: activation curves were obtained by plotting the 
normalized tail current versus the membrane potential. 
WT blue curve, F291I red curve. 
 
 
3.2.  Computational results 
The TTP ventricular cell computer model was used to 
study the effects of mutant channels on AP morphology 
in epicardial and M cells (Figure 2). In particular, 
concerning the steady state activation we introduced a 
negative shift of 25 mV between wild type and mutant. In 
addition, we scaled the activation time constant, τf, and τs, 
by a factor equal to the ratio between measured F279I, 
and WT values (Table 1).  
Simulated IKs in the F279I homozygous condition 
shortened the AP with respect to the WT one, from 397 to 
297 ms in M cells (Figure 1A, right panel). The F279I- 
induced AP shortening is due to the presence of a 
significant increase in the outward K+ current during 
phases 3 of the AP (Figure 2A, lower panels). The F279I 
channel did not induce significant additional changes in 
AP morphology with respect to WT. When simulating the 
β-adrenergic stimulation, the APD behavior was similar, 
as shown in Table 2 and figure 2B. 
In the ORd model the mutation also induced APD 
shortening, but much less pronounced (Figure 3A). APD 
reduction was almost negligible in basal conditions while 
it was enhanced by adrenergic stimulation (up to 23 ms 
shortening in M cells, Figure 3B, right panel). 
Pseudo-ECG was simulated in order to assess the QT 
interval shortening using both models as described in the 
methods. The results are shown in figure 4: where we can 
appreciate a significant reduction of the interval using the 
TT model and less with the ORd. 
 
 
 
 
 
 
 
Figure 2. (A) Comparison of ventricular AP (top) and 
IKs current (bottom) in wild-type (WT, blue curve) and 
F279I (red curve) conditions for epicardial (left) and M 
(right) cells (basic cycle length: 1000 ms), simulated 
using the TTP model. (B) Simulation of β-adrenergic 
stimulation in the same conditions as in (A). 
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Figure 3. (A) Comparison of ventricular action 
potentials (top) and IKs current (bottom) in wild-type 
(WT, blue curve) and F279I (red curve) conditions for 
epicardial (left) and M (right) cells (basic cycle length: 
1000 ms), simulated using the ORd model. (B) 
Simulation of β-adrenergic stimulation in the same 
conditions as in (A). 
 
 
 
Figure 4. Pseudo ECG performed with TTP (top) and 
ORd (bottom) model.  
 
4. Discussion and conclusion 
Kv7.1 is the alpha subunit of the ion channel complex 
underlying IKs that, together with IKr, are the major 
repolarizing current in ventricle. Gain of function 
mutations on Kv7.1 cause SQT2. This mutation modifies 
the gating of the WT channel.  
The electrophysiological characteristics associated 
with the mutation are expected to lead enhance 
repolarization with shortening of the QT interval 
(leftward shift of the activation curve, faster activation 
kinetics). 
The use of mathematical models to simulate mutant 
conditions proved useful in order to demonstrate its 
effects on the AP. The significant differences between the 
results with the two models is due to the different 
formulation of IKs. The weight of this current in human 
APD is actually still a matter of debate and deserves a 
detailed analysis. Also the compute of the pseudo ECG 
confirmed the shortening effects of the QT interval. 
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